State NY
Clinical Trials in New York
New York is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New York and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 686 actively recruiting studies with New York sites out of 686 registered in total. The busiest research areas in New York are Breast Cancer, Prostate Cancer, Colorectal Cancer. Leading sponsors running trials in the state include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai. By stage, New York trials break down as Phase 1 (127), Phase 2 (170), Phase 3 (126), Phase 4 (27).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New York
Frequently Asked Questions — Clinical Trials in New York
How many clinical trials are currently recruiting in New York?
ClinicalMetric currently tracks 686 actively recruiting clinical trials with at least one location in New York. The total number of registered studies—including active but not currently enrolling trials—is 686. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New York?
New York hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New York serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New York?
To join a clinical trial in New York, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New York maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New York
NCT07339111 Phase 3
Recruiting
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cart...
Condition
Knee Cartilage Defects
Enrollment
300 pts
Location
United States
Sponsor
Medipost, Inc.
NCT07510373 N/A
Recruiting
Opioid Tapering After Hospital Discharge: Testing an Intervention to Improve Pos...
Condition
Opioid Tapering
Enrollment
42 pts
Location
United States
Sponsor
Montefiore Medical Center
NCT05245695 N/A
Recruiting
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affe...
Condition
Endometriosis
Enrollment
1,200 pts
Location
United States
Sponsor
Aspira Women's Health
NCT00556530 N/A
Recruiting
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Condition
DiGeorge Syndrome
Enrollment
1,000 pts
Location
United States
Sponsor
Albert Einstein College of Med
NCT06563895 Phase 3
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) S...
Condition
Amyloidosis
Enrollment
587 pts
Location
United States, Argentina, Australia
Sponsor
Eidos Therapeutics, a BridgeBi
NCT06872905 N/A
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endopros...
Condition
Aortoiliac Occlusive Disease
Enrollment
158 pts
Location
United States, Italy, Netherlands
Sponsor
W.L.Gore & Associates
NCT05095207 Phase 1, Phase 2
Recruiting
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER...
Condition
Breast Cancer
Enrollment
42 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo
NCT03507257 N/A
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Condition
Early Onset Alzheimer Disease
Enrollment
850 pts
Location
United States, Argentina, Netherlands
Sponsor
Indiana University
NCT06895070 N/A
Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Ac...
Condition
Heart Transplant
Enrollment
60 pts
Location
United States
Sponsor
XVIVO Perfusion
NCT05227937 N/A
Recruiting
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
Condition
Urinary Tract Infections
Enrollment
75 pts
Location
United States
Sponsor
Antonios Likourezos
NCT07384975 Phase 2
Recruiting
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Condition
Hidradenitis Suppurativa (HS)
Enrollment
150 pts
Location
United States
Sponsor
Navigator Medicines, Inc.
NCT06039930 N/A
Recruiting
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation
Condition
Depression
Enrollment
140 pts
Location
United States
Sponsor
Weill Medical College of Corne
NCT07309445 N/A
Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With N...
Condition
Non-Muscle Invasive Bladder Neoplasms
Enrollment
150 pts
Location
United States
Sponsor
Janssen Research & Development
NCT07439471 N/A
Recruiting
Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and...
Condition
Cigarette Smoking-Related Carcinoma
Enrollment
40 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT05420064 N/A
Recruiting
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mut...
Condition
BRCA1 Mutation
Enrollment
1,000 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05763251 N/A
Recruiting
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Condition
Invasive Candidiasis
Enrollment
420 pts
Location
United States, Australia
Sponsor
Arkansas Children's Hospital R
NCT06876831 N/A
Recruiting
Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Scr...
Condition
Lung Cancer Screening Program
Enrollment
150 pts
Location
United States
Sponsor
Physician Affiliate Group of N
NCT05215353 Phase 4
Recruiting
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in ...
Condition
Survivorship
Enrollment
368 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07391657 Phase 3
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antig...
Condition
Relapsed Refractory Multiple Myeloma
Enrollment
508 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
NCT07641361 N/A
Recruiting
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Thera...
Condition
Obesity & Overweight
Enrollment
30 pts
Location
United States
Sponsor
State University of New York a
NCT06938841 N/A
Recruiting
Maintenance rTMS for Depression (Maitr-De)
Condition
Major Depressive Disorder
Enrollment
75 pts
Location
United States, Australia
Sponsor
University of California, San
NCT05564494 N/A
Recruiting
Surgical Treatment of Recurrent Shoulder Dislocations
Condition
Shoulder Instability
Enrollment
200 pts
Location
United States, Canada
Sponsor
Nova Scotia Health Authority
NCT06401356 Phase 3
Recruiting
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Condition
Hematologic Malignancy
Enrollment
50 pts
Location
United States, Belgium, Italy
Sponsor
Novartis Pharmaceuticals
NCT06588556 N/A
Recruiting
Improving Needs Among Older Adults
Condition
Critical Illness
Enrollment
350 pts
Location
United States
Sponsor
Duke University
NCT06911424 Phase 3
Recruiting
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Condition
Bacterial Conjunctivitis
Enrollment
400 pts
Location
United States
Sponsor
Baxis Pharmaceuticals, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology